Alzheimer’s Treatment Centers of America (ATCA) provides personalized care for people with Alzheimer’s, dementia and cognitive decline. Its approach combines AI analysis, brain imaging, genetic information and more than 50 therapeutic modalities to create individualized treatment plans aimed at addressing the underlying contributors to cognitive decline. At its Palm Beach Gardens clinic, ATCA brings diagnostics and treatment together in one coordinated care setting.
In a two-year observational study of ATCA’s AI protocol, 80% of participants reported no further decline in mild cognitive impairment (MCI). The company incorporates this protocol into its personalized approach to cognitive care, combining AI-guided analysis with clinician-led assessment and treatment planning.
In a two-year observational study of ATCA’s AI protocol, 80% of participants reported no further decline in mild cognitive impairment (MCI). The company incorporates this protocol into its personalized approach to cognitive care, combining AI-guided analysis with clinician-led assessment and treatment planning.
In a two-year observational study of ATCA’s AI protocol, 80% of participants reported no further decline in mild cognitive impairment (MCI). The company incorporates this protocol into its personalized approach to cognitive care, combining AI-guided analysis with clinician-led assessment and treatment planning.
Register Here to
View Pitch Deck
“The AI-guided approach is unlike anything else we tried. My mom is more alert and engaged than she’s been in years.”
The Team
Dr. George F. Moricz, MD
Physician — Cognitive Health & Lifestyle Medicine.
A physician with more than two decades of experience spanning functional and regenerative medicine. Dr. Moricz trained at the University of Massachusetts Medical School and is the author of Root Cause Medicine. He helps shape ATCA’s personalized diagnostic and treatment protocols, bringing clinical experience in individualized care to the company’s approach.
Dr. Joshua Helman, MD
Physician — Cognitive Health & Lifestyle Medicine.
A Harvard-trained physician board-certified in emergency medicine and lifestyle medicine. Dr. Helman holds biochemistry degrees from Harvard and the University of Cambridge, with clinical interests spanning cognitive health, nutrition and metabolic health. His background combines medical practice with an emphasis on diet and lifestyle in personalized care.
Jaswinder “Manji” Matharu
Medical Advisory Board — Artificial Intelligence & Computer
A technology entrepreneur and founder of predictive analytics company Agilis International, which was acquired by Infogix. He also founded S3Net and Fiducainet, acquired by Safeguard Scientifics and Neustar respectively. His background brings experience in analytics, technology development and building businesses to ATCA’s advisory board.
Register Here to
View Pitch Deck
Register Here to
View Pitch Deck
Interested in Investing in Healthcare Innovation?
